Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
This study has been completed.
Study NCT01325350   Information provided by Allergan

First Received on March 28, 2011.   Last Updated on November 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alopecia
Baldness
Additional conditions recognized in this trial
Alopecia Areata
More general conditions related to this trial
Hair Diseases
Hypotrichosis
Pathological Conditions, Anatomical
Skin Diseases
Interventions listed in this trial
bimatoprost Formulation A
bimatoprost Formulation B
bimatoprost Formulation C
bimatoprost vehicle solution
minoxidil 2% solution
Additional drug interventions recognized in this trial
Bimatoprost
Cloprostenol
Minoxidil
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Contraceptive Agents
Contraceptive Agents, Female
Luteolytic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services